Extracellular ATP and P2 purinergic signalling in the tumour microenvironment

Nature Reviews. Cancer
Francesco Di VirgilioE Adinolfi

Abstract

Modulation of the biochemical composition of the tumour microenvironment is a new frontier of cancer therapy. Several immunosuppressive mechanisms operate in the milieu of most tumours, a condition that makes antitumour immunity ineffective. One of the most potent immunosuppressive factors is adenosine, which is generated in the tumour microenvironment owing to degradation of extracellular ATP. Accruing evidence over the past few years shows that ATP is one of the major biochemical constituents of the tumour microenvironment, where it acts at P2 purinergic receptors expressed on both tumour and host cells. Stimulation of P2 receptors has different effects depending on the extracellular ATP concentration, the P2 receptor subtype engaged and the target cell type. Among P2 receptors, the P2X purinergic receptor 7 (P2X7R) subtype appears to be a main player in host-tumour cell interactions. Preclinical studies in several tumour models have shown that P2X7R targeting is potentially a very effective anticancer treatment, and many pharmaceutical companies have now developed potent and selective small molecule inhibitors of P2X7R. In this Review, we report on the multiple mechanisms by which extracellular ATP shapes the tumour microenv...Continue Reading

References

Dec 15, 1975·Biochemical and Biophysical Research Communications·E Rozengurt, L A Heppel
Jun 1, 1977·The Journal of Physiology·T Forrester, C A Williams
Jun 11, 1992·Nature·R J EvansA Surprenant
Aug 1, 1972·British Journal of Cancer·S Nolde, H Hilz
Sep 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·G J GasicC C Stewart
Jun 15, 1980·The Biochemical Journal·S Cockcroft, B D Gomperts
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K D LustigD Julius
Dec 1, 1996·Journal of Autonomic Pharmacology·S PirottonJ M Boeynaems
Sep 11, 1999·Neuron·B S Khakh, H A Lester
Nov 24, 1999·The Journal of Biological Chemistry·O R BaricordiF Di Virgilio
Mar 31, 2000·Molecular Medicine Today·L J McCawley, L M Matrisian
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D FerrariF Di Virgilio
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A la SalaG Girolomoni
Dec 1, 2001·Immunity·A MacKenzieA Surprenant
Sep 25, 2002·Physiological Reviews·R Alan North
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Aaron J MarcusRoberto Levi
May 22, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Gennady G YegutkinSirpa Jalkanen
May 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Philip A VerhoefGeorge R Dubyak
Jul 15, 2003·Molecular Biology of the Cell·Anna MorelliFrancesco Di Virgilio
Mar 6, 2004·Breast Cancer Research and Treatment·Michael SlaterJulian A Barden
Oct 12, 2004·Leukemia Research·Xiu-Jun ZhangKe-Fu Wu
Jun 10, 2005·Molecular Biology of the Cell·Patrizia PellegattiFrancesco Di Virgilio
Jul 5, 2005·The Journal of Biological Chemistry·Amanda B MackenzieAnnmarie Surprenant
Dec 31, 2005·The New England Journal of Medicine·Deborah A ZarinNicholas C Ide
Feb 3, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sylvia O SuadicaniEliana Scemes
Aug 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Akio OhtaMichail Sitkovsky
Dec 16, 2006·Science·Yu ChenWolfgang G Junger
Jan 6, 2007·The Journal of Physiology·Gennady G YegutkinJosé González-Alonso
Feb 23, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marcello BaroniFrancesco Di Virgilio
Apr 13, 2007·Physiological Reviews·Geoffrey Burnstock
Apr 24, 2007·Free Radical Biology & Medicine·Zachary A PfeifferPaul J Bertics
Sep 8, 2007·The American Journal of Pathology·Shaun W JacksonSimon C Robson
Mar 8, 2008·BJU International·Majid ShabbirGeoffrey Burnstock

❮ Previous
Next ❯

Citations

Jun 5, 2019·Cancers·Giorgia ScarpellinoLuca Munaron
May 1, 2019·International Journal of Molecular Sciences·Giuseppe SammarcoRiccardo Memeo
Oct 23, 2019·Frontiers in Immunology·Tiziana VaisittiSilvia Deaglio
Feb 26, 2020·Expert Opinion on Biological Therapy·Susan F Slovin
Mar 8, 2020·Cellular & Molecular Immunology·Juliang QinBing Du
Mar 12, 2020·American Journal of Physiology. Cell Physiology·Francesco Di VirgilioRobson Coutinho-Silva
Apr 1, 2020·Current Eye Research·Heung-Mo YangHynda Kleinman
Mar 26, 2020·International Journal of Cancer. Journal International Du Cancer·Yueqing GongJunjie Wang
Feb 27, 2020·Journal for Immunotherapy of Cancer·David AllardJohn Stagg
Mar 27, 2020·Journal for Immunotherapy of Cancer·Lorenzo GalluzziFrancesco M Marincola
Apr 5, 2020·Cell Research·Qiuheng JinSheng Ye
Aug 27, 2019·Oncotarget·Letícia Scussel BergaminFrancesco Di Virgilio
Sep 3, 2020·Journal of Leukocyte Biology·Henrique Borges da Silva
Oct 5, 2020·Purinergic Signalling·Francesco Di Virgilio
Jan 25, 2019·Biochemical Society Transactions·Ralf FliegertAndreas H Guse
Apr 30, 2019·Frontiers in Immunology·Anna Lisa GiulianiFrancesco Di Virgilio
Jun 28, 2019·Frontiers in Immunology·Selena ViganoGeorge Coukos
Dec 10, 2019·Stem Cell Reviews and Reports·Vanessa Fernandes Arnaud-SampaioClaudiana Lameu
Apr 2, 2020·Frontiers in Pharmacology·Mahmoud G KhalafallaGary A Weisman
Apr 9, 2020·Frontiers in Oncology·Valentina AudritoSilvia Deaglio
Jun 3, 2020·International Journal of Cancer. Journal International Du Cancer·Daniela GalleranoEleonora Timperi
Jun 26, 2020·Frontiers in Pharmacology·Romain LaraShaun McNulty
Aug 13, 2020·Journal of Pancreatic Cancer·Ming TanMaiken Thyregod Jøergensen
Sep 14, 2018·Seminars in Immunopathology·Michael W Graner
Feb 14, 2019·Nature Communications·Mark A LobasBaljit S Khakh
May 16, 2019·The Biochemical Journal·Liziane Raquel BeckenkampMárcia Rosângela Wink
Dec 6, 2018·International Journal of Molecular Sciences·Kevin SekPaul A Beavis
Apr 4, 2019·Frontiers in Immunology·Marta VuerichMaria Serena Longhi
Aug 21, 2019·Immunometabolism·Kelsey M WanhainenHenrique Borges da Silva
Mar 15, 2020·Purinergic Signalling·Marta Schmidt PfaffenzellerAndréia Machado Cardoso
Jul 17, 2020·International Journal of Molecular Sciences·Elizabeth Rivas-YáñezDaniela Sauma
Aug 8, 2020·Nature Reviews. Clinical Oncology·Lorenzo GalluzziGuido Kroemer
Sep 7, 2020·Journal of Cancer Research and Clinical Oncology·Qianqian LiRonglan Zhao

❮ Previous
Next ❯

Datasets Mentioned

BETA
MDA-MB-435S

Methods Mentioned

BETA
biopsy
xenograft
GTPase

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Microbes and Infection
Amel RayahFrancesco Di Virgilio
Current Opinion in Pharmacology
Francesco Di VirgilioE Adinolfi
The Journal of Pharmacology and Experimental Therapeutics
Geoffrey Burnstock, M Williams
Journal of Biological Regulators and Homeostatic Agents
G MancinoFrancesco Di Virgilio
© 2022 Meta ULC. All rights reserved